These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 18678887)

  • 1. Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis.
    Aharoni R; Herschkovitz A; Eilam R; Blumberg-Hazan M; Sela M; Bruck W; Arnon R
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11358-63. PubMed ID: 18678887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
    Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
    J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate.
    Moore S; Khalaj AJ; Patel R; Yoon J; Ichwan D; Hayardeny L; Tiwari-Woodruff SK
    J Neurosci Res; 2014 Dec; 92(12):1621-36. PubMed ID: 24989965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetate.
    From R; Eilam R; Bar-Lev DD; Levin-Zaidman S; Tsoory M; LoPresti P; Sela M; Arnon R; Aharoni R
    Glia; 2014 Apr; 62(4):649-65. PubMed ID: 24481644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of Adult Endogenous Neural Stem/Progenitor Cells in the Spinal Cord to Contribute to Remyelination in Experimental Autoimmune Encephalomyelitis.
    Maeda Y; Nakagomi N; Nakano-Doi A; Ishikawa H; Tatsumi Y; Bando Y; Yoshikawa H; Matsuyama T; Gomi F; Nakagomi T
    Cells; 2019 Sep; 8(9):. PubMed ID: 31484369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing remyelination - metabolic labeling of myelin in an animal model of multiple sclerosis.
    Aharoni R; Rosen C; Shezen E; Bar-Lev DD; Golani O; Reisner Y; Sela M; Arnon R
    J Neuroimmunol; 2016 Dec; 301():7-11. PubMed ID: 27836179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bu Shen Yi Sui capsule promotes remyelination correlating with Sema3A/NRP-1, LIF/LIFR and Nkx6.2 in mice with experimental autoimmune encephalomyelitis.
    Zhao PY; Wang YQ; Liu XH; Zhu YJ; Zhao H; Zhang QX; Qi F; Li JL; Zhang N; Fan YP; Li KN; Zhao YY; Lei JF; Wang L
    J Ethnopharmacol; 2018 May; 217():36-48. PubMed ID: 29428242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
    Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
    J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
    Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
    Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
    Aharoni R
    J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective Effect of Glatiramer Acetate on Neurofilament Light Chain Leakage and Glutamate Excess in an Animal Model of Multiple Sclerosis.
    Aharoni R; Eilam R; Lerner S; Shavit-Stein E; Dori A; Chapman J; Arnon R
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes.
    Talbott JF; Loy DN; Liu Y; Qiu MS; Bunge MB; Rao MS; Whittemore SR
    Exp Neurol; 2005 Mar; 192(1):11-24. PubMed ID: 15698615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
    Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis.
    Paintlia AS; Paintlia MK; Khan M; Vollmer T; Singh AK; Singh I
    FASEB J; 2005 Sep; 19(11):1407-21. PubMed ID: 16126908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate.
    Skihar V; Silva C; Chojnacki A; Döring A; Stallcup WB; Weiss S; Yong VW
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17992-7. PubMed ID: 19815532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis.
    Gilgun-Sherki Y; Panet H; Holdengreber V; Mosberg-Galili R; Offen D
    Neurosci Res; 2003 Oct; 47(2):201-7. PubMed ID: 14512144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunomodulator glatiramer acetate influences spinal motoneuron plasticity during the course of multiple sclerosis in an animal model.
    Marques KB; Scorisa JM; Zanon R; Freria CM; Santos LM; Damasceno BP; Oliveira AL
    Braz J Med Biol Res; 2009 Feb; 42(2):179-88. PubMed ID: 19274346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.
    Girolamo F; Errede M; Longo G; Annese T; Alias C; Ferrara G; Morando S; Trojano M; Kerlero de Rosbo N; Uccelli A; Virgintino D
    PLoS One; 2019; 14(3):e0213508. PubMed ID: 30870435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.